SCHEMBL7076175

SCHEMBL7076175

O=C(O)c1cc2cc(N3CCOCC3)ccc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMAD3 P84022 1/20 0.51
KDM4E B2RXH2 3/20 0.50
HPGD P15428 2/20 0.50
HSD17B10 Q99714 2/20 0.50
ALDH1A1 P00352 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
F7 P08709 1/20 0.50
F3 P13726 1/20 0.50
PIN1 Q13526 1/20 0.50
PDPK1 O15530 1/20 0.50
LMNA P02545 1/20 0.50
TSHR P16473 1/20 0.50
NFKB1 P19838 1/20 0.50
APEX1 P27695 1/20 0.50
CYP2C19 P33261 1/20 0.50
KMO O15229 1/20 0.50
POLB P06746 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
SLC16A3 O15427 1/20 0.48
PDE3B Q13370 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6307136 0.81 KDM4E (0.60) KDM4EHPGDHSD17B10ALDH1A1LMNA
SCHEMBL15642612 0.80 PIN1 (0.50) SMAD3KDM4EHPGDHSD17B10ALDH1A1
SCHEMBL17927550 0.79 MAP3K11 (0.46) HSD17B10ALDH1A1POLBSMN1; SMN2PDE3B
SCHEMBL1486903 0.77 PDE3B (0.48) KDM4EHPGDHSD17B10ALDH1A1TDP1
SCHEMBL19538285 0.76 KDM4E (0.41) SMAD3KDM4EHPGDHSD17B10ALDH1A1
SCHEMBL19538219 0.76 FGFR1 (0.47) SMAD3KDM4EHPGDHSD17B10ALDH1A1
SCHEMBL30492866 0.75 HRH4 (0.53) KDM4EHPGDHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL1643417 0.74 KMO (0.68) KDM4EHPGDHSD17B10ALDH1A1TDP1
SCHEMBL13460613 0.73 PDGFRB (0.77) KDM4EHPGDHSD17B10ALDH1A1TSHR
SCHEMBL25044341 0.72 SMAD3 (0.51) SMAD3KDM4EHPGDHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003504-B1 INDOLE DERIVATIVES AND THEIR USE AS MCP-1 ANTAGONISTS ASTRAZENECA AB (SE) 2003-07-02 EP disclosed